{"id":"W4311089805","doi":"10.1016/j.antiviral.2022.105484","title":"Discovery of lead natural products for developing pan-SARS-CoV-2 therapeutics","year":2022,"lang":"en","type":"article","venue":"Antiviral Research","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Centre for Disease Control; Université de Sherbrooke; Simon Fraser University; University of British Columbia","funders":"Mitacs; National Institute of Allergy and Infectious Diseases; Canadian Institutes of Health Research; Genome British Columbia","keywords":"Bafilomycin; Virology; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Vero cell; EC50; Monoclonal antibody; Cell culture; Chemistry; Microbiology; In vitro; Coronavirus disease 2019 (COVID-19); Biology; Virus; Medicine; Biochemistry; Antibody; Immunology; Infectious disease (medical specialty); Disease","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"bench_or_experimental","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low","status":"direct model label, unvalidated"},{"model":"gpt","categories":[],"domain":null,"study_design":"bench_or_experimental","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high","status":"direct model label, unvalidated"}],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002459554,0.000189542,0.000411655,0.0005516497,0.0004165318,0.00007607804,0.0005315496,0.00007493061,1.918507e-7],"category_scores_gemma":[0.0008288093,0.0001614327,0.0001655267,0.001546997,0.0003996282,0.0002677264,0.0006225447,0.00108371,0.00002578195],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003191245,"about_ca_system_score_gemma":0.001702644,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002471715,"about_ca_topic_score_gemma":0.00003864478,"domain_scores_codex":[0.9960085,0.0003406034,0.0003713391,0.0005784484,0.001765818,0.0009352591],"domain_scores_gemma":[0.9978901,0.0006447893,0.00007226346,0.0005822356,0.0008067124,0.000003892681],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001434323,0.000246788,0.003468053,0.0004264415,0.0001256737,0.00005312321,0.0003957599,5.451671e-9,0.9789035,0.001881715,0.001648775,0.01141585],"study_design_scores_gemma":[0.001264938,0.0008760539,0.001841029,0.00006875435,0.00002015964,0.00001885718,0.0005970562,0.000300147,0.9757851,0.0007853926,0.0182646,0.0001779384],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9926713,0.001322975,0.00014608,0.00282362,0.0002350677,0.001457347,0.00003429499,0.00004200893,0.001267279],"genre_scores_gemma":[0.9923635,0.00002811739,0.0005219283,0.005667995,0.000233974,0.0002680101,0.00002067523,0.00005733597,0.0008384321],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01661582,"threshold_uncertainty_score":0.6583035,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2106674548316415,"score_gpt":0.4596793827760708,"score_spread":0.2490119279444293,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}